Lifecore Biomedical, Inc. De (LFCR) Capital Leases (2016 - 2024)

Lifecore Biomedical's Capital Leases history runs 8 years deep, the most recent figure standing at $3.2 million for Q2 2024.

• In Q2 2024, Capital Leases changed 0.03% year-over-year to $3.2 million; the TTM figure through May 2024 stood at $3.2 million (changed 0.03% YoY), while the FY2024 annual figure was $3.2 million, changed 0.03% from the prior year.
• Capital Leases was $3.2 million for Q2 2024 at Lifecore Biomedical, roughly flat from $3.2 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $26.4 million in Q2 2020 to a low of $12000.0 in Q2 2022.
• Historically, Capital Leases has averaged $7.3 million across 4 years, with a median of $3.2 million in 2024.
• The sharpest annual moves came in 2020 and 2023: Capital Leases slipped 2.67% in 2020, then surged 26683.33% in 2023.
• A 4-year view of Capital Leases shows it stood at $26.4 million in 2020, then tumbled by 99.95% to $12000.0 in 2022, then soared by 26683.33% to $3.2 million in 2023, then rose by 0.03% to $3.2 million in 2024.
• The last three Capital Leases figures came in at $3.2 million (Q2 2024), $3.2 million (Q2 2023), and $12000.0 (Q2 2022), per Business Quant data.